Dr. Danita Sanborn is a clinical cardiologist and a specialist in Echocardiography. She is the Physician Director of Clinical Operations for the Cardiology Division. She also a core educator cardiology, serving as an Associate Program Director for the Cardiovascular Fellowship and as the Medical Director of the Paul Dudley White Associates Cardiology Fellows' Ambulatory Practice.
Dr. Sanborn received her MD degree from the University of Iowa College of Medicine. She completed residency training in Internal Medicine and fellowship training in Cardiovascular Disease with an advanced fellowship in Echocardiography at Massachusetts General Hospital. She joined the faculty in the Cardiology Division at MGH and Harvard Medical School. During her fellowship, she also completed Harvard Medical School's Scholars in Clinical Science Program and earned a Masters of Medical Science Degree from HMS. She holds board certifications in Cardiovascular Disease from the ABIM as well as Comprehensive Certification in Echocardiography from the NBE. She is a fellow of both the American College of Cardiology and the American Society of Echocardiography.
Her clinical interests include comprehensive echocardiography, general clinical cardiology, valve disease, cardiomyopathy and structural heart disease with specialized expertise in echocardiographic guidance of septal ablation, left atrial appendage occlusion and ASD/PFO closure.
Dr. Sanborn's research interests include refining the role of echocardiography as a tool to better understand uncommon cardiomyopathies including Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) and Hypertrophic Cardiomyopathy. She managed the Echo Core Lab for the Multidisciplinary Study of ARVC and participated with a group of experts who proposed Modifications of the original Task Force Criteria for the diagnosis of ARVC. She has also participated in studies examining echocardiographic predictors of atrial fibrillation and cardiovascular outcomes in stroke patients and in patients with valvular heart disease and hypertrophic cardiomyopathy. She has served on the Board of Directors for the American Society of Echocardiography, is on the editorial board of the Journal of the American Society of Echocardiography and served on numerous ASE Committees and Task Forces, including as chair of the CME Committee. She has also served as Editor in Chief of American College of Cardiology's EchoSAP and is a member of the Editorial Board of ACC's Collaborative Maintenance Pathway.
Departments, Centers, & Programs:
Clinical Interests:
Treats:
Mass General Heart Center
55 Fruit St.
Boston, MA 02114
Phone: 866-644-8910
Medical Education
American Board Certifications
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Dr. Sanborn's research interests include defining and refining the role of echocardiography as a tool to better understand uncommon cardiomyopathies including Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) and Hypertrophic Cardiomyopathy. She managed the Echo Core Lab for the North American Multidisciplinary Study of ARVC and participated with a group of experts who proposed Modifications of the original Task Force Criteria for the diagnosis of ARVC, published in 2010. She has also used her expertise in echocardiography to collaborate with colleagues at MGH to study echocardiographic predictors of atrial fibrillation in cryptogenic stroke and the genetic basis of cardiovascular diseases including atrial fibrillation and cardiomyopathy.
Select Publications:
Yoerger, DM, Marcus, F, et al, Echocardiographic Findings in Patients Meeting Task Force Criteria for ARVD; JACC, 2005; 45: 860-65.
